Archives: Doctors

Professor of Pharmacogenetics, Translational and Clinical Research Institute, Newcastle University, UK (since August 2004). Member, Pharmacovigilance Expert Advisory Group, Commission on Human Medicines, MHRA (2017-2024). Chair, European Society of Pharmacogenomics and Personalised Therapy (ESPT) (2023-2024). Vice-chair, IUPHAR Pharmacogenetics subcommittee (2018-2023). Committee member, UK Pharmacogenetics and Stratified Medicine Network (since 2014). Senior Editor, British Journal of Clinical Pharmacology. Editorial Board Member, Clinical Pharmacology & Therapeutics, Pharmacogenetics & Genomics, Journal of Pharmacology & Experimental Therapeutics, Pharmacogenomics.

Ph.D., The University of Manchester; Molecular Cancer Researcher; Assistant Professor of Clinical Pharmacology. Experienced Research Fellow with a demonstrated history of working in the pharmaceuticals industry. Skilled in Good Laboratory Practice (GLP), Validation, GMP, Neurobehavioral Pharmacology, and Molecular Biology. Strong professional with a Doctor of Philosophy – Ph.D. focused in Clinical Pharmacology from The University of Manchester. A Ph.D. research project at the University of Manchester focused on identifying and quantifying O6-alkylguanine adducts in human colorectal DNA (both normal and tumor samples). The project aimed to develop a novel mass spectrometry-based methodology to achieve these goals. Outstanding experience in undergraduate teaching both at the University of Manchester as well as several Egyptian public and private universities.

Dr. Rehab Bahy has been a Lecturer of Microbiology and Immunology at the Faculty of Pharmacy/ Fayoum University from 2019 till now. Before 2019, she worked at the National Authority of Drug Control And Research (NODCAR)from 2009 – 2019 as a Teaching assistant first and then as Researcher; from 2003-2009 as a Quality Control Specialist of Biologicals, then as Technical Manager at The National Regulatory Authority for Biological Products, Vaccines and Sera (NRA).

She has good experience dealing with different Iso standards and WHO qualification indicators. She was a member of the GLP team participating with the Pharmaceutical Administration CAPA, Ministry of Health, in a regular inspection of pharmaceutical companies inside and outside Egypt. She completed her Master’s and Ph.D. in pharmaceutical sciences (Microbiology and Immunology) at Cairo University, Egypt. She supervises two Master’s degree students and participates in another two master’s degrees. She was an ESPID (European Society for Pediatric Infectious Diseases) member from 2016-2019. She has 7 scientific papers published in international journals with research interests in Infectious diseases, Antibiotic resistance, Microbial Virulence factors, Antimicrobials from natural sources, and Vaccines.

I have a proven track record in successfully deploying complex solutions and business change with an absolute focus on realizing tangible benefits for the business. What most inspired me is working in challenging roles that enable me to deliver comprehensive solutions internally and externally. My genuine passion is for developing solutions to deliver improvements that significantly impact business operations. my drive and determination to achieve outstanding results and thrive in highly pressurized and challenging working environments give me pride and motivation.
The type of role which excites me is one where I can strive to improve engagement to drive business to meet both short-term and long-term profitability. I enjoy being part of a successful and productive team and thriving in a highly pressurized working environment. I ensure exceptional attention to detail and strive to provide exceptional results in everything that I do, and I always Seek excellence from myself as well as from the team and peers I work with.

Ahmed Azzam has a strong background in information technology (IT) and management. He has held various positions in the field, including Deputy IT Manager, Project Manager-IT Infrastructure Supervisor, Computing Services Team Leader, Systems Engineer, and Operations Engineer.

In his current role as Deputy IT Manager at Nile University in Egypt, Ahmed is responsible for contributing to the development of IT departmental strategies, identifying technology investments, handling the annual budget, managing a team, and ensuring the consistency and maintainability of existing applications.

Prior to his current position, Ahmed served as a Project Manager-IT Infrastructure Supervisor at Nile University, where he performed service analysis, prepared request for proposals, conducted market research, analyzed solutions, and managed all the implementation phases of different ICT projects.

Ahmed’s experience also includes serving as a Computing Services Team Leader, where he conducted proof of concept tests, managed the budget of the Computing Services division, developed operations manuals, identified highly qualified candidates, hired, trained, led and evaluated their performance in achieving goals, and developed and updated the Information and Communication Technology (ICT) policy.

In addition to his professional experience, Ahmed holds a Master of Science in Management of Technology from Nile University, Egypt. He has also been involved in several previous projects, including the implementation of Students Information System, ERP system, and HR system.

Noha Abdelkader is a Professor at the Pharmacology and Toxicology Department, Faculty of Pharmacy, Cairo University. Prof. Abdelkader is a member in the board of directors of the National center for Clinical and Environmental Toxicology, Faculty of Medicine, Cairo University. Prof. Abdelkader has received her B.Sc. degree in Pharmaceutical Sciences from Cairo University, Cairo, Egypt in 2000. She received her M.Sc. and Ph.D. degrees in Pharmaceutical Sciences from Cairo University in Egypt in 2006 and 2011 respectively. She coordinated a major EU funded project in the Erasmus+KA2 scheme (Project ITCT: IT-Based Clinical Toxicology Diploma, 2015-2019) that involved 4 Egyptian partners representing the 4 biggest universities in Egypt alongside 3 European universities from Sweden, UK, and Malta. This project was extended by joint research with University of Newcastle, UK about preclinical toxicity studies of ionic liquids. Moreover, Prof. Noha Abdelkader is the external expert for the EU funded OPPM project (Online Pharmacogenomics and Personalized Medicine postgraduate program, 2022-2025). Prof. Abdelkader has published 33 articles in highly ranked peer reviewed journals (h-index: 16, citations: 713). Her research is focused on exploring new treatment strategies for neurodegenerative disorders, cancer, chemotherapy-induced toxicities, diabetes, and peripheral neuropathy which are considered major health related problems in Egypt as well as the whole world. Prof. Abdelkader has participated in many international conferences and scientific workshops. She has supervised 11 MSc and 11 PhD students. For her contribution to the learning and research process at Cairo University, Prof. Abdelkader was awarded the University Encouragement Award in Medical and Pharmaceutical Sciences in 2017. Prof. Abdelkader was also recognized by the EU delegation in Egypt and the Ministry of Higher Education and Scientific Research in Egypt for her valuable contribution in strengthening EU – Egypt cooperation in research, innovation, and higher education in 2019.

Professor Rajaa Fakhoury is a professor of Medical Biochemistry; she has completed her MSc from the American University of Beirut, Medical School, Department of Biochemistry and her PhD from Manchester University Medical School, Department of Rheumatology and postdoctoral studies from the same university department of Integrated Genomic Medical Research. After her graduation from Manchester University in 1993, she joined Beirut Arab University, Faculty of Pharmacy, Department of Biochemistry and Pharmacology. She worked at King Saud Bin Abdel Aziz University for Health Sciences and at Alfaisal University, College of Medicine. Currently, Professor Fakhoury is the dean of the Faculty of Health Sciences, Beirut Arab University. She has published more than 40 papers in the field of Molecular Medicine and Pharmacogenomics.

Dr. Mona Allouba is a post-doctoral researcher and manager of the Genetics and Genomics unit at Aswan Heart Centre (AHC). She completed her PhD studies in Cardiovascular Clinical Research Medicine at Imperial College London in collaboration with AHC in 2020. Her research focuses on identifying the genetic determinants of Hypertrophic Cardiomyopathy in the Egyptian population with the aim to improve diagnosis, disease management and potentially treatment of this life-threatening disease.

 

Marina Sous is the Scientific Project Manager of the Life Sciences Department at the Aswan Heart Centre – Magdi Yacoub Foundation (MYF). She completed her Bachelor of Science from the American University in Cairo with a major in Biology. In 2017, she obtained her Doctor of Pharmacy Degree (PharmD) from Massachusetts College of Pharmacy and Health Sciences (MCPHS) with highest honors. Dr. Sous has gained valuable knowledge and experience as a pharmacist from working in different pharmacy settings. Her current role mainly focuses on population study management (The Ballana Heart Study), pulmonary hypertension clinical trial management. She is currently completing her Master of Public Health (MPH) at Johns Hopkins University. Her field of interest is the examination of cardiovascular disease prevalence & epidemiology, strategies for disease prevention and development of awareness campaigns to promote cardiovascular health.

 

Yasmine Aguib holds a doctoral degree in molecular biotechnology and molecular medicine from the Technische Universität München (Germany). Currently she is co-Director of the Research Centre at Magdi Yacoub Foundation (Egypt), hon. senior research fellow at the National Heart and Lung Institute (Imperial College London -UK) and is serving as member of the MYF management board. Aguib is Co-PI in the Foundation Leducq Transatlantic Networks of Excellence for ‘Redox Regulation of Cardiomyocyte Renewal’. In the frame of the German Excellence Initiative she was appointed scientific consultant to the TUM president in the fields of life sciences and international strategic alliances where she contributed to the establishment of the TUM Global Strategy and the EuroTech Universities Alliance. She is a scientific board member of the newly launched Egypt Genome Project and founding member of the GPx Network ( funded by the DAAD in the 2019), and the Epi/Genomic Medicine and Health Equity Autumn School. Her current work focuses on understanding the role of molecular determinants of heart disease, its etiology and manifestation in the Egyptian and North African population and on contributing to the advancement of genomic CV medicine in Africa and globally.